BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2819703)

  • 1. No influence of enzyme inhibitors on the hydroxylation of methotrexate in rats.
    Yu D; Brasch H; Iven H
    Cancer Lett; 1989 Nov; 48(2):153-6. PubMed ID: 2819703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo-in vitro relationship of methotrexate 7-hydroxylation by aldehyde oxidase in four different strain rats.
    Moriyasu A; Sugihara K; Nakatani K; Ohta S; Kitamura S
    Drug Metab Pharmacokinet; 2006 Dec; 21(6):485-91. PubMed ID: 17220564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strain differences of the ability to hydroxylate methotrexate in rats.
    Kitamura S; Nakatani K; Sugihara K; Ohta S
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1999 Mar; 122(3):331-6. PubMed ID: 10336093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of 7-hydroxymethotrexate formation by amsacrine.
    Bremnes RM; Smeland E; Willassen NP; Wist E; Aarbakke J
    Cancer Chemother Pharmacol; 1991; 28(5):377-83. PubMed ID: 1914082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation and elimination of 7-hydroxymethotrexate in the rat in vivo after methotrexate administration.
    Bremnes RM; Slørdal L; Wist E; Aarbakke J
    Cancer Res; 1989 May; 49(9):2460-4. PubMed ID: 2706634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldehyde oxidase-catalysed oxidation of methotrexate in the liver of guinea-pig, rabbit and man.
    Jordan CG; Rashidi MR; Laljee H; Clarke SE; Brown JE; Beedham C
    J Pharm Pharmacol; 1999 Apr; 51(4):411-8. PubMed ID: 10385213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of methotrexate (MTX) and 7-hydroxymethotrexate (7-OH-MTX) in rats and evidence for the metabolism of MTX to 7-OH-MTX.
    Fahrig L; Brasch H; Iven H
    Cancer Chemother Pharmacol; 1989; 23(3):156-60. PubMed ID: 2924373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of antibiotics and uricosuric drugs on the renal elimination of methotrexate and 7-hydroxymethotrexate in rabbits.
    Iven H; Brasch H
    Cancer Chemother Pharmacol; 1988; 21(4):337-42. PubMed ID: 3370743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent pharmacokinetics of methotrexate and 7-hydroxymethotrexate in the rat in vivo.
    Bremnes RM; Slørdal L; Wist E; Aarbakke J
    Cancer Res; 1989 Nov; 49(22):6359-64. PubMed ID: 2804982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vitro study on methotrexate hydroxylation in rat and human liver.
    Chládek J; Martínková J; Sispera L
    Physiol Res; 1997; 46(5):371-9. PubMed ID: 9728483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of lipophilicity and carboxyl group content on the rate of hydroxylation of methotrexate derivatives by aldehyde oxidase.
    Rosowsky A; Wright JE; Holden SA; Waxman DJ
    Biochem Pharmacol; 1990 Aug; 40(4):851-7. PubMed ID: 1696821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of vindesine on methotrexate hydroxylation in the rat.
    Bremnes RM; Smeland E; Slørdal L; Wist E; Aarbakke J
    Biochem Pharmacol; 1991 Sep; 42(8):1561-8. PubMed ID: 1930283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic synthesis of polyglutamate derivatives of 7-hydroxymethotrexate.
    McGuire JJ; Hsieh P; Bertino JR
    Biochem Pharmacol; 1984 Apr; 33(8):1355-61. PubMed ID: 6201178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of aldehyde oxidase and xanthine oxidase in the biotransformation of a novel negative allosteric modulator of metabotropic glutamate receptor subtype 5.
    Morrison RD; Blobaum AL; Byers FW; Santomango TS; Bridges TM; Stec D; Brewer KA; Sanchez-Ponce R; Corlew MM; Rush R; Felts AS; Manka J; Bates BS; Venable DF; Rodriguez AL; Jones CK; Niswender CM; Conn PJ; Lindsley CW; Emmitte KA; Daniels JS
    Drug Metab Dispos; 2012 Sep; 40(9):1834-45. PubMed ID: 22711749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nutritional status on the hepatobiliary excretion of methotrexate in the rat.
    Grossie VB; Loo TL
    Cancer Treat Rep; 1983 Mar; 67(3):253-7. PubMed ID: 6403239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxylation of 4-amino-antifolates by partially purified aldehyde oxidase from rabbit liver.
    Fabre G; Seither R; Goldman ID
    Biochem Pharmacol; 1986 Apr; 35(8):1325-30. PubMed ID: 2421732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No effect of phenobarbital pretreatment of rats on methotrexate pharmacokinetics in the isolated liver perfused in a single-pass way.
    Chládek J; Martínková J; Sispera L; Chládková J; Cermanová J
    Pharmacology; 2001 Feb; 62(2):92-7. PubMed ID: 11174078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental changes of aldehyde oxidase in postnatal rat liver.
    Tayama Y; Moriyasu A; Sugihara K; Ohta S; Kitamura S
    Drug Metab Pharmacokinet; 2007 Apr; 22(2):119-24. PubMed ID: 17495419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of aldehyde oxidase in ethanol-induced hepatic lipid peroxidation in the rat.
    Shaw S; Jayatilleke E
    Biochem J; 1990 Jun; 268(3):579-83. PubMed ID: 2363695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following infusions of high-dose methotrexate.
    Breithaupt H; Küenzlen E
    Cancer Treat Rep; 1982 Sep; 66(9):1733-41. PubMed ID: 6956440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.